Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.03
AKR's Cash-to-Debt is ranked lower than
53% of the 655 Companies
in the Global REIT - Retail industry.

( Industry Median: 0.06 vs. AKR: 0.03 )
Ranked among companies with meaningful Cash-to-Debt only.
AKR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.12 Max: N/A
Current: 0.03
Equity-to-Asset 0.39
AKR's Equity-to-Asset is ranked lower than
74% of the 684 Companies
in the Global REIT - Retail industry.

( Industry Median: 0.51 vs. AKR: 0.39 )
Ranked among companies with meaningful Equity-to-Asset only.
AKR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18  Med: 0.29 Max: 0.51
Current: 0.39
0.18
0.51
Interest Coverage 0.45
AKR's Interest Coverage is ranked lower than
96% of the 664 Companies
in the Global REIT - Retail industry.

( Industry Median: 3.72 vs. AKR: 0.45 )
Ranked among companies with meaningful Interest Coverage only.
AKR' s Interest Coverage Range Over the Past 10 Years
Min: 0.45  Med: 1.17 Max: 1.38
Current: 0.45
0.45
1.38
Piotroski F-Score: 3
Altman Z-Score: 0.62
Beneish M-Score: -2.39
WACC vs ROIC
4.20%
0.47%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 8.68
AKR's Operating Margin % is ranked lower than
86% of the 692 Companies
in the Global REIT - Retail industry.

( Industry Median: 49.17 vs. AKR: 8.68 )
Ranked among companies with meaningful Operating Margin % only.
AKR' s Operating Margin % Range Over the Past 10 Years
Min: 8.68  Med: 26.83 Max: 33.72
Current: 8.68
8.68
33.72
Net Margin % 29.85
AKR's Net Margin % is ranked lower than
51% of the 693 Companies
in the Global REIT - Retail industry.

( Industry Median: 39.81 vs. AKR: 29.85 )
Ranked among companies with meaningful Net Margin % only.
AKR' s Net Margin % Range Over the Past 10 Years
Min: 18.17  Med: 30.42 Max: 52.68
Current: 29.85
18.17
52.68
ROE % 4.19
AKR's ROE % is ranked lower than
58% of the 696 Companies
in the Global REIT - Retail industry.

( Industry Median: 6.34 vs. AKR: 4.19 )
Ranked among companies with meaningful ROE % only.
AKR' s ROE % Range Over the Past 10 Years
Min: 4.19  Med: 8.81 Max: 14.68
Current: 4.19
4.19
14.68
ROA % 1.65
AKR's ROA % is ranked lower than
67% of the 700 Companies
in the Global REIT - Retail industry.

( Industry Median: 3.31 vs. AKR: 1.65 )
Ranked among companies with meaningful ROA % only.
AKR' s ROA % Range Over the Past 10 Years
Min: 1.65  Med: 2.26 Max: 3.24
Current: 1.65
1.65
3.24
ROC (Joel Greenblatt) % 1.71
AKR's ROC (Joel Greenblatt) % is ranked lower than
73% of the 585 Companies
in the Global REIT - Retail industry.

( Industry Median: 16.50 vs. AKR: 1.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AKR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.71  Med: 5.42 Max: 12.44
Current: 1.71
1.71
12.44
3-Year Revenue Growth Rate -6.60
AKR's 3-Year Revenue Growth Rate is ranked lower than
82% of the 500 Companies
in the Global REIT - Retail industry.

( Industry Median: 2.50 vs. AKR: -6.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AKR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.1  Med: 1.55 Max: 11.3
Current: -6.6
-26.1
11.3
3-Year EBITDA Growth Rate 1.30
AKR's 3-Year EBITDA Growth Rate is ranked lower than
59% of the 457 Companies
in the Global REIT - Retail industry.

( Industry Median: 4.30 vs. AKR: 1.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AKR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -3.45 Max: 36
Current: 1.3
0
36
3-Year EPS without NRI Growth Rate 15.50
AKR's 3-Year EPS without NRI Growth Rate is ranked higher than
64% of the 404 Companies
in the Global REIT - Retail industry.

( Industry Median: 5.40 vs. AKR: 15.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AKR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -10  Med: 13.5 Max: 38.7
Current: 15.5
-10
38.7
GuruFocus has detected 8 Warning Signs with Acadia Realty Trust $AKR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AKR's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

AKR Guru Trades in Q2 2016

Paul Tudor Jones 12,667 sh (New)
Pioneer Investments 100,700 sh (+1.41%)
Jim Simons Sold Out
Ken Fisher 1,048,332 sh (-0.64%)
Chris Davis 484,458 sh (-33.98%)
» More
Q3 2016

AKR Guru Trades in Q3 2016

Ken Fisher 1,064,074 sh (+1.50%)
Chris Davis 484,457 sh (unchged)
Paul Tudor Jones Sold Out
Pioneer Investments 97,300 sh (-3.38%)
» More
Q4 2016

AKR Guru Trades in Q4 2016

Paul Tudor Jones 11,440 sh (New)
Chris Davis 497,226 sh (+2.64%)
Ken Fisher 1,033,784 sh (-2.85%)
Pioneer Investments 87,200 sh (-10.38%)
» More
Q1 2017

AKR Guru Trades in Q1 2017

Paul Tudor Jones 12,218 sh (+6.80%)
Chris Davis 499,011 sh (+0.36%)
Ken Fisher 1,023,338 sh (-1.01%)
Pioneer Investments 82,200 sh (-5.73%)
» More
» Details

Insider Trades

Latest Guru Trades with AKR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: REITs » REIT - Retail    NAICS: 531120    SIC: 6798
Compare:OTCPK:FRIVF, NYSE:SKT, NAS:ROIC, NYSE:ALX, NYSE:AAT, NYSE:RPAI, NYSE:KRG, NYSE:WPG, NYSE:SRG, NYSE:CBL, NYSE:DDR, NYSE:BFS, NYSE:ADC, OTCPK:SGLMF, NYSE:TCO, OTCPK:CWYUF, NYSE:RPT, OTCPK:PPRQF, OTCPK:CMPNF, NYSE:GTY » details
Traded in other countries:WX1.Germany,
Headquarter Location:USA
Acadia Realty Trust is a real estate investment trust. It is engaged in the ownership, acquisition, redevelopment and management of retail properties located in supply-constrained, densely-populated metropolitan areas in the United States.

Acadia Realty Trust is a real estate investment trust which specialises in the operation, management, leasing, renovation, and acquisition of shopping centres and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which includes the properties of the trust and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

Top Ranked Articles about Acadia Realty Trust

Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)

THOROFARE, NJ--(Marketwired - Jun 27, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR) (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has signed its first distribution agreement for BreathScan OxiChek™ ("OxiChek") with Aero-Med, a division of Cardinal Health, a Fortune 500 health care services organization. Developed by Akers Bio as part of the Akers Wellness line, OxiChek is the first disposable breath test to rapidly determine levels of oxidative stress in the body by measuring the levels of certain abundant free radicals. Frequent use of OxiChek may help health practitioners to monitor and adjust their clients' regimen of nutritional supplementation in order to manage oxidative stress -- an indicator of the overall health and wellbeing of a person. OxiChek works with BreathScan Lync™, the new Bluetooth-enabled reading device from Akers Wellness, to enable users to monitor oxidative stress via a mobile device.  Aero-Med is targeting the large specific markets in the United States of anti-aging, functional and integrative health and wellness treatment practitioners and has already placed orders for OxiChek. OxiChek will be initially represented by an Aero-Med sales team focusing on the six New England states both through direct sales and, in due course, through an e-commerce platform under development. Akers Bio intends to appoint further partners for OxiChek with distribution capabilities within other target markets for OxiChek including chiropractors and multi-level marketing organizations.  "The US health practitioner market is the most diverse in the world," said John J. Gormally, CEO of Akers Bio. "OxiChek targets many of these different potential user bases so we needed a distributor with the broadest reach and I can think of no organization better suited than Aero-Med, which has extensive access to our target markets. I have worked with Aero-Med in the past and have been highly impressed with their distribution capabilities," continued Mr. Gormally. Dan DelMastro, CEO of Aero-Med, added, "Aero-Med recognizes the enormous market potential for products within the health and wellness sector so we are delighted to be incorporating OxiChek into our sales offering. Having personally observed the positive customer reaction to OxiChek at conventions in recent months, I am optimistic that there is strong potential for this product." About Akers Biosciences, Inc. Akers Biosciences develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and its products can be found at www.akersbio.com. Follow us on Twitter @AkersBio. Cautionary Statement Regarding Forward Looking Statements Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Akers Biosciences, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3026507




For more information:



Akers Biosciences, Inc.

Raymond F. Akers, Jr., PhD

Co-founder and Chief Scientific Director

Tel. 1 856 848 8698



Taglich Brothers, Inc. (Investor Relations)

Chris Schreiber

Tel. 1 917 445 6207

Email: [email protected]



Vigo Communications (Public Relations)

Ben Simons / Fiona Henson

Tel. 44 (0)20 7830 9700

Email: [email protected]





Read more...

Ratios

vs
industry
vs
history
PE Ratio 38.20
AKR's PE Ratio is ranked lower than
78% of the 613 Companies
in the Global REIT - Retail industry.

( Industry Median: 16.89 vs. AKR: 38.20 )
Ranked among companies with meaningful PE Ratio only.
AKR' s PE Ratio Range Over the Past 10 Years
Min: 9.21  Med: 27.72 Max: 48.82
Current: 38.2
9.21
48.82
Forward PE Ratio 44.64
AKR's Forward PE Ratio is ranked lower than
92% of the 342 Companies
in the Global REIT - Retail industry.

( Industry Median: 19.49 vs. AKR: 44.64 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 38.20
AKR's PE Ratio without NRI is ranked lower than
78% of the 612 Companies
in the Global REIT - Retail industry.

( Industry Median: 17.20 vs. AKR: 38.20 )
Ranked among companies with meaningful PE Ratio without NRI only.
AKR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.35  Med: 37.02 Max: 1127.67
Current: 38.2
13.35
1127.67
PB Ratio 1.47
AKR's PB Ratio is ranked lower than
74% of the 685 Companies
in the Global REIT - Retail industry.

( Industry Median: 1.12 vs. AKR: 1.47 )
Ranked among companies with meaningful PB Ratio only.
AKR' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 2.21 Max: 3.85
Current: 1.47
1.23
3.85
PS Ratio 11.11
AKR's PS Ratio is ranked lower than
81% of the 655 Companies
in the Global REIT - Retail industry.

( Industry Median: 7.50 vs. AKR: 11.11 )
Ranked among companies with meaningful PS Ratio only.
AKR' s PS Ratio Range Over the Past 10 Years
Min: 2.09  Med: 8.79 Max: 14.71
Current: 11.11
2.09
14.71
Price-to-Operating-Cash-Flow 19.03
AKR's Price-to-Operating-Cash-Flow is ranked lower than
77% of the 567 Companies
in the Global REIT - Retail industry.

( Industry Median: 14.68 vs. AKR: 19.03 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AKR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.34  Med: 18.73 Max: 45.38
Current: 19.03
3.34
45.38
EV-to-EBIT 122.04
AKR's EV-to-EBIT is ranked lower than
89% of the 892 Companies
in the Global REIT - Retail industry.

( Industry Median: 21.84 vs. AKR: 122.04 )
Ranked among companies with meaningful EV-to-EBIT only.
AKR' s EV-to-EBIT Range Over the Past 10 Years
Min: -379.8  Med: 37.2 Max: 587.5
Current: 122.04
-379.8
587.5
EV-to-EBITDA 39.28
AKR's EV-to-EBITDA is ranked lower than
87% of the 904 Companies
in the Global REIT - Retail industry.

( Industry Median: 17.01 vs. AKR: 39.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
AKR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.9  Med: 21.4 Max: 93.2
Current: 39.28
9.9
93.2
PEG Ratio 3.71
AKR's PEG Ratio is ranked lower than
62% of the 240 Companies
in the Global REIT - Retail industry.

( Industry Median: 2.17 vs. AKR: 3.71 )
Ranked among companies with meaningful PEG Ratio only.
AKR' s PEG Ratio Range Over the Past 10 Years
Min: 0.72  Med: 3.36 Max: 423.94
Current: 3.71
0.72
423.94
Shiller PE Ratio 29.01
AKR's Shiller PE Ratio is ranked lower than
60% of the 198 Companies
in the Global REIT - Retail industry.

( Industry Median: 24.18 vs. AKR: 29.01 )
Ranked among companies with meaningful Shiller PE Ratio only.
AKR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.03  Med: 29.61 Max: 76.23
Current: 29.01
12.03
76.23
Current Ratio 0.50
AKR's Current Ratio is ranked lower than
69% of the 651 Companies
in the Global REIT - Retail industry.

( Industry Median: 0.96 vs. AKR: 0.50 )
Ranked among companies with meaningful Current Ratio only.
AKR' s Current Ratio Range Over the Past 10 Years
Min: 0.5  Med: 4 Max: 9.81
Current: 0.5
0.5
9.81
Quick Ratio 0.50
AKR's Quick Ratio is ranked lower than
66% of the 651 Companies
in the Global REIT - Retail industry.

( Industry Median: 0.90 vs. AKR: 0.50 )
Ranked among companies with meaningful Quick Ratio only.
AKR' s Quick Ratio Range Over the Past 10 Years
Min: 0.5  Med: 4 Max: 9.81
Current: 0.5
0.5
9.81
Days Sales Outstanding 92.99
AKR's Days Sales Outstanding is ranked lower than
89% of the 495 Companies
in the Global REIT - Retail industry.

( Industry Median: 17.68 vs. AKR: 92.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
AKR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.08  Med: 74.6 Max: 385.52
Current: 92.99
50.08
385.52

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 3.64
AKR's Dividend Yield % is ranked lower than
88% of the 918 Companies
in the Global REIT - Retail industry.

( Industry Median: 5.21 vs. AKR: 3.64 )
Ranked among companies with meaningful Dividend Yield % only.
AKR' s Dividend Yield % Range Over the Past 10 Years
Min: 2.57  Med: 3.2 Max: 9.44
Current: 3.64
2.57
9.44
Dividend Payout Ratio 0.62
AKR's Dividend Payout Ratio is ranked higher than
55% of the 706 Companies
in the Global REIT - Retail industry.

( Industry Median: 1.06 vs. AKR: 0.62 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AKR' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.62  Med: 1.24 Max: 1.68
Current: 0.62
0.62
1.68
3-Year Dividend Growth Rate 5.50
AKR's 3-Year Dividend Growth Rate is ranked higher than
60% of the 392 Companies
in the Global REIT - Retail industry.

( Industry Median: 4.20 vs. AKR: 5.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AKR' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.1 Max: 10.8
Current: 5.5
0
10.8
Forward Dividend Yield % 3.75
AKR's Forward Dividend Yield % is ranked lower than
90% of the 920 Companies
in the Global REIT - Retail industry.

( Industry Median: 5.45 vs. AKR: 3.75 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 5.32
AKR's 5-Year Yield-on-Cost % is ranked lower than
70% of the 920 Companies
in the Global REIT - Retail industry.

( Industry Median: 6.04 vs. AKR: 5.32 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AKR' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.76  Med: 4.68 Max: 13.81
Current: 5.32
3.76
13.81
3-Year Average Share Buyback Ratio -14.50
AKR's 3-Year Average Share Buyback Ratio is ranked lower than
73% of the 425 Companies
in the Global REIT - Retail industry.

( Industry Median: -5.70 vs. AKR: -14.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AKR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -48.8  Med: -7.75 Max: 0.9
Current: -14.5
-48.8
0.9

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 1.59
AKR's Price-to-Tangible-Book is ranked lower than
75% of the 677 Companies
in the Global REIT - Retail industry.

( Industry Median: 1.13 vs. AKR: 1.59 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AKR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.78  Med: 2.06 Max: 3.68
Current: 1.59
0.78
3.68
Price-to-Median-PS-Value 1.26
AKR's Price-to-Median-PS-Value is ranked lower than
83% of the 521 Companies
in the Global REIT - Retail industry.

( Industry Median: 1.08 vs. AKR: 1.26 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AKR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.1  Med: 0.59 Max: 1.64
Current: 1.26
0.1
1.64
Price-to-Graham-Number 1.64
AKR's Price-to-Graham-Number is ranked lower than
76% of the 539 Companies
in the Global REIT - Retail industry.

( Industry Median: 0.95 vs. AKR: 1.64 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AKR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.72  Med: 1.74 Max: 9.47
Current: 1.64
0.72
9.47
Earnings Yield (Greenblatt) % 0.82
AKR's Earnings Yield (Greenblatt) % is ranked lower than
83% of the 914 Companies
in the Global REIT - Retail industry.

( Industry Median: 4.46 vs. AKR: 0.82 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AKR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.2  Med: 2.7 Max: 7.3
Current: 0.82
0.2
7.3
Forward Rate of Return (Yacktman) % -19.51
AKR's Forward Rate of Return (Yacktman) % is ranked lower than
60% of the 385 Companies
in the Global REIT - Retail industry.

( Industry Median: 2.48 vs. AKR: -19.51 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AKR' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -27.7  Med: -2.05 Max: 20.9
Current: -19.51
-27.7
20.9

More Statistics

Revenue (TTM) (Mil) $199.3
EPS (TTM) $ 0.73
Beta0.52
Short Percentage of Float12.74%
52-Week Range $26.70 - 38.01
Shares Outstanding (Mil)84.73

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $)
EPS ($) 0.62 0.06 0.01
EPS without NRI ($) 0.62 0.06 0.01
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 1.05 1.07
» More Articles for AKR

Headlines

Articles On GuruFocus.com
7 High-Yield Stocks With a Negative 1-Year Performance Feb 03 2017 
Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM) Jun 27 2016 
Akers Biosciences Reports Earnings for Q1 2016 May 12 2016 
Akers Biosciences to Present at 'Pioneers 2016' Investor Conference May 04 2016 
82 Shareholder Friendly Stocks of the Week Nov 10 2014 
Let's Take a Closer Look at Macerich Apr 09 2014 
My 5 Favorites Stocks With Dividend Growth From Last Week Mar 03 2013 
Urstadt Biddle Properties (UBA) Dividend Stock Analysis Nov 30 2012 
Acadia Realty Trust Reports Operating Results (10-K) Feb 28 2011 
Acadia Realty Trust (AKR) CFO Michael Nelsen sells 5,004 Shares Feb 22 2011 

More From Other Websites
Edited Transcript of AKR earnings conference call or presentation 25-Apr-17 4:00pm GMT May 18 2017
Acadia Realty Trust Announces $0.26 Per Share Quarterly Dividend May 11 2017
Acadia Realty Trust breached its 50 day moving average in a Bearish Manner : AKR-US : April 25, 2017 Apr 25 2017
Blog Coverage Kennedy-Wilson Holdings to Merge with Kennedy-Wilson Europe; Set to Create a Leading... Apr 25 2017
Acadia Realty Trust reports 1Q results Apr 24 2017
Acadia Realty Trust Reports First Quarter 2017 Operating Results Apr 24 2017
REITs' Q1 Earnings to Watch on Apr 24: UDR, CCI & Others Apr 21 2017
Acadia Realty Trust breached its 50 day moving average in a Bullish Manner : AKR-US : April 14, 2017 Apr 14 2017
Acadia Realty Trust to Announce First Quarter 2017 Earnings on April 24, 2017 Mar 28 2017
Acadia Realty Trust Announces 2017 Annual Meeting Date Mar 24 2017
Acadia Realty Trust to Present at the Citi 2017 Global Property CEO Conference Mar 02 2017
New Strong Sell Stocks for March 1st Mar 01 2017
Acadia Realty Trust :AKR-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017 Feb 17 2017
Edited Transcript of AKR earnings conference call or presentation 15-Feb-17 5:00pm GMT Feb 15 2017
Acadia Realty Trust : AKR-US: Dividend Analysis : December 30th, 2016 (record date) : By the numbers... Feb 15 2017
Acadia Realty Trust breached its 50 day moving average in a Bearish Manner : AKR-US : February 15,... Feb 15 2017
Acadia Realty Trust Reports Fourth Quarter and Full Year 2016 Operating Results Feb 14 2017
Acadia Realty Trust Completes $1.1 Billion of Transactions in 2016 Jan 18 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)